A detailed history of Clearstead Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 1,420 shares of BIIB stock, worth $224,218. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,420
Previous 1,457 2.54%
Holding current value
$224,218
Previous $337,000 18.4%
% of portfolio
0.0%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$189.07 - $236.8 $6,995 - $8,761
-37 Reduced 2.54%
1,420 $275,000
Q2 2024

Aug 09, 2024

BUY
$190.52 - $236.72 $3,048 - $3,787
16 Added 1.11%
1,457 $337,000
Q1 2024

May 14, 2024

SELL
$212.02 - $267.71 $82,051 - $103,603
-387 Reduced 21.17%
1,441 $310,000
Q4 2023

Feb 12, 2024

BUY
$222.59 - $267.94 $25,375 - $30,545
114 Added 6.65%
1,828 $473,000
Q3 2023

Nov 13, 2023

BUY
$253.3 - $285.89 $18,997 - $21,441
75 Added 4.58%
1,714 $440,000
Q3 2023

Nov 07, 2023

BUY
$253.3 - $285.89 $48,380 - $54,604
191 Added 13.19%
1,639 $421,000
Q2 2023

Aug 07, 2023

SELL
$275.25 - $318.06 $825 - $954
-3 Reduced 0.21%
1,448 $412,000
Q1 2023

May 09, 2023

SELL
$256.56 - $292.34 $513 - $584
-2 Reduced 0.14%
1,451 $403,000
Q1 2022

May 04, 2022

BUY
$193.77 - $244.14 $43,792 - $55,175
226 Added 18.42%
1,453 $306,000
Q4 2021

Feb 14, 2022

BUY
$223.92 - $287.77 $47,694 - $61,295
213 Added 21.01%
1,227 $294,000
Q2 2021

Aug 12, 2021

BUY
$259.0 - $414.71 $127,428 - $204,037
492 Added 94.25%
1,014 $351,000
Q1 2021

May 14, 2021

BUY
$242.95 - $284.63 $33,527 - $39,278
138 Added 35.94%
522 $146,000
Q3 2020

Nov 12, 2020

BUY
$264.77 - $305.71 $30,183 - $34,850
114 Added 42.22%
384 $109,000
Q1 2020

May 14, 2020

BUY
$268.85 - $341.04 $72,589 - $92,080
270 New
270 $85,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.